Over the first reporting period we have initiated developments towards our three project objectives. We have been able to advance towards further miniaturization of the flexible intraneural arrays, complementing photolithography with direct writing methods. We have developed chemical functionalization protocols for incorporating anti-inflammatory substances on the polyimide surfaces for subsequent controlled release, and furthermore explored new agents targeting reduced foreign body response in vitro, with an ongoing follow up in vivo. We are currently processing the first batch of biofunctionalized miniaturized intraneural arrays. Biofunctionalization is expected to have positive effects on tissue integration but there can also be negative effects on device integrity, something we are analyzing in our ongoing work.